"I look forward to assisting the team make progress on its global drug registration goals." Dr Smith has also held senior leadership positions at Allergan plc, AstraZeneca and Bristol-Myers Squibb. She has an MD from the University of Warwick (UK), PhD in Molecular Oncology from UCLA (USA) and University of Western Australia (Australia), an MBA from the University of New England in Australia and an LLM (Masters in Law) from the University of Salford (UK).